<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00962013</url>
  </required_header>
  <id_info>
    <org_study_id>53</org_study_id>
    <nct_id>NCT00962013</nct_id>
  </id_info>
  <brief_title>Restoration® Modular Revision Hip System Post Market Study</brief_title>
  <official_title>A Prospective Open-Label Evaluation of the Restoration® Modular System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Orthopaedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate survivorship of the femoral stem at 5 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The two-piece modular revision stem components are intended to be used for primary or
      revision total hip arthroplasty, as well as in the presence of severe proximal bone loss.
      This study evaluates the System in revision cases only. The stems are intended to be used
      with Stryker Orthopaedics femoral heads, unipolar and bipolar components, and acetabular
      components. These femoral stems are designed to be press fit into the proximal femur.

      In addition to demonstrating survivorship at 5 years, this study will seek to gain
      information on four secondary objectives: radiographic stability, Harris Hip Scores, SF-36
      general well-being assessment, and safety profile.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stem Survivorship (%)</measure>
    <time_frame>5 years</time_frame>
    <description>Failure is defined by stem revision for any cause.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Femoral Stem Fracture</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiographic Stability</measure>
    <time_frame>5 years</time_frame>
    <description>Absence of a radiolucent lines ≥ 2mm around the entire stem in AP or ML view.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>pre-op and 5 years</time_frame>
    <description>Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score less than or equal to 79 is considered fair-poor.
90 - 100 = excellent
80 - 89 = good
70 - 79 = fair
0 - 69 = poor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 Health Status Survey: Role - Physical</measure>
    <time_frame>pre-op, 2 year and 5 year</time_frame>
    <description>Consists of 8 subscores all with a range of 0-100; a higher score indicates a better health state:
The subscores are: 1 - Physical Functioning, 2 - Role-Physical, 3 - Bodily Pain, 4 - General Health, 5 - Vitality, 6 - Social Functioning, 7- Role-Emotional, 8 - Mental Health
This Secondary Outcome Measure is focused on the &quot;Role-Physical&quot; score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-surgery Femoral Crack/Fracture and Subsidence Rate</measure>
    <time_frame>Post-op to 5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">137</enrollment>
  <condition>Arthroplasty, Replacement, Hip</condition>
  <arm_group>
    <arm_group_label>Restoration® Modular</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All subjects were enrolled into a single arm and received the Restoration® Modular Revision Hip System to replace the femoral portion of a failed previous implant.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Restoration® Modular Revision Hip System</intervention_name>
    <description>Restoration® Modular Revision System</description>
    <arm_group_label>Restoration® Modular</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Candidates for cementless revision of a failed femoral prosthesis.

          -  Patients willing to sign the informed consent.

          -  Patients able to comply with follow-up requirements including post-operative
             weightbearing restrictions and self-evaluations.

          -  Male and non-pregnant female patients ages 18 to 85 years of age at the time of
             surgery.

        Exclusion Criteria:

          -  Patients with ongoing infection.

          -  Patients who are severely immunocompromised.

          -  Patients who are prisoners.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Barnett, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedic Specialty Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael W Britt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedic Associates of Corpus Christi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth A Greene, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Crystal Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven F Harwin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>D. Christopher Hikes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence Health &amp; Services</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kirby Hitt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Scott and White Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Hozack, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rothman Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frederick Jaffe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Joint Diseases</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Timothy P Lovell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence Orthopaedic Specialties</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark R Matthes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Iowa Orthopaedic Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arthur Malkani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jewish Hospital Center for Advanced Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Schurman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kansas Joint and Spine Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Wright, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New West Sports Medicine and Orthopaedic Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Orthopaedic Specialty Institute</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Orthopaedic Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kansas Joint and Spine Institute</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jewish Hospital Center for Advanced Medicine</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New West Sports Medicine and Orthopaedic Surgery</name>
      <address>
        <city>Kearney</city>
        <state>Nebraska</state>
        <zip>68847</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital for Joint Diseases</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Crystal Clinic</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44333</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Portland Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopedic Associates of Corpus Christi</name>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <zip>78411</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scott and White Hospital</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Orthopaedic Specialities</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 13, 2009</study_first_submitted>
  <study_first_submitted_qc>August 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2009</study_first_posted>
  <results_first_submitted>April 4, 2014</results_first_submitted>
  <results_first_submitted_qc>July 24, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 15, 2014</results_first_posted>
  <last_update_submitted>February 10, 2017</last_update_submitted>
  <last_update_submitted_qc>February 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>137/139 participants/hips enrolled and 17/17 participants/hips censored=120/122 participants/hips started</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Restoration® Modular</title>
          <description>All subjects were enrolled into a single arm and received the Restoration® Modular Revision Hip System to replace the femoral portion of a failed previous implant.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="120"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52">Number of participants with 5 year primary endpoint data</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not have surgery</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unable/Unwilling to return</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Removal of study device</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Site Termination</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No 5 year evaluation</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Includes participants who received the Restoration® Modular Hip System and were not censored from analysis.</population>
      <group_list>
        <group group_id="B1">
          <title>Restoration® Modular</title>
          <description>All subjects were enrolled into a single arm and received the Restoration® Modular Revision Hip System to replace the femoral portion of a failed previous implant.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="120"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Age results are based on 118 participants as there were 2 participants missing age data. For bilateral participants, age at the time surgery for the first hip enrolled is used for the baseline measurement.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.72" spread="12.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Stem Survivorship (%)</title>
        <description>Failure is defined by stem revision for any cause.</description>
        <time_frame>5 years</time_frame>
        <population>Participants with 5 year follow-up evaluations or participant had a stem revision before they reached 5 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Restoration® Modular</title>
            <description>All subjects were enrolled into a single arm and received the Restoration Modular Revision Hip System to replace the femoral portion of a failed previous implant.</description>
          </group>
        </group_list>
        <measure>
          <title>Stem Survivorship (%)</title>
          <description>Failure is defined by stem revision for any cause.</description>
          <population>Participants with 5 year follow-up evaluations or participant had a stem revision before they reached 5 years.</population>
          <units>stem survivorship percentage at 5 years</units>
          <param>Number</param>
          <dispersion>90% Confidence Interval</dispersion>
          <units_analyzed>hips</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>hips</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.64" lower_limit="89.69" upper_limit="99.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>This revision study will demonstrate a 5-year survivorship of the Restoration Modular system not seven percent worse than an expected 95% survival rate using a lower 95% one-sided confidence bound.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>non-inferiority margin is 7%</non_inferiority_desc>
            <p_value>0.0136</p_value>
            <method>Exact Binomial</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Radiographic Stability</title>
        <description>Absence of a radiolucent lines ≥ 2mm around the entire stem in AP or ML view.</description>
        <time_frame>5 years</time_frame>
        <population>41 hips had fully evaluable radiographs at the 5 year interval; 40 out of the 41 hips are stable.</population>
        <group_list>
          <group group_id="O1">
            <title>Restoration® Modular</title>
            <description>All subjects were enrolled into a single arm and received the Restoration Modular Revision Hip System to replace the femoral portion of a failed previous implant.</description>
          </group>
        </group_list>
        <measure>
          <title>Radiographic Stability</title>
          <description>Absence of a radiolucent lines ≥ 2mm around the entire stem in AP or ML view.</description>
          <population>41 hips had fully evaluable radiographs at the 5 year interval; 40 out of the 41 hips are stable.</population>
          <units>percentage of stable hips</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>hips</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>hips</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.6" lower_limit="87.1" upper_limit="99.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Harris Hip Score</title>
        <description>Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score less than or equal to 79 is considered fair-poor.
90 - 100 = excellent
80 - 89 = good
70 - 79 = fair
0 - 69 = poor</description>
        <time_frame>pre-op and 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Restoration® Modular</title>
            <description>All subjects were enrolled into a single arm and received the Restoration Modular Revision Hip System to replace the femoral portion of a failed previous implant.</description>
          </group>
        </group_list>
        <measure>
          <title>Harris Hip Score</title>
          <description>Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score less than or equal to 79 is considered fair-poor.
90 - 100 = excellent
80 - 89 = good
70 - 79 = fair
0 - 69 = poor</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>hips</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="110"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>hips</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="110"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mean HHS Pre-op N=110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.33" spread="16.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean HHS 5 years N=45</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.27" spread="10.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Change from HHS pre-op to HHS 5 year</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SF-36 Health Status Survey: Role - Physical</title>
        <description>Consists of 8 subscores all with a range of 0-100; a higher score indicates a better health state:
The subscores are: 1 - Physical Functioning, 2 - Role-Physical, 3 - Bodily Pain, 4 - General Health, 5 - Vitality, 6 - Social Functioning, 7- Role-Emotional, 8 - Mental Health
This Secondary Outcome Measure is focused on the &quot;Role-Physical&quot; score.</description>
        <time_frame>pre-op, 2 year and 5 year</time_frame>
        <population>SF-36 Scores were assessed for each hip. (One hip did not have a pre-operative SF-36)</population>
        <group_list>
          <group group_id="O1">
            <title>Restoration® Modular</title>
            <description>All subjects were enrolled into a single arm and received the Restoration Modular Revision Hip System to replace the femoral portion of a failed previous implant.</description>
          </group>
        </group_list>
        <measure>
          <title>SF-36 Health Status Survey: Role - Physical</title>
          <description>Consists of 8 subscores all with a range of 0-100; a higher score indicates a better health state:
The subscores are: 1 - Physical Functioning, 2 - Role-Physical, 3 - Bodily Pain, 4 - General Health, 5 - Vitality, 6 - Social Functioning, 7- Role-Emotional, 8 - Mental Health
This Secondary Outcome Measure is focused on the &quot;Role-Physical&quot; score.</description>
          <population>SF-36 Scores were assessed for each hip. (One hip did not have a pre-operative SF-36)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>hips</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>hips</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>SF-36 Role-Physical Pre-op N=121</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.21" spread="10.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF-36 Role-Physical 2 year N=86</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.25" spread="12.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF-36 Role-Physical 5 year N=45</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.66" spread="13.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Change from SF-36 Role-Physical pre-op score to 2 and 5 year scores</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Femoral Stem Fracture</title>
        <time_frame>5 years</time_frame>
        <population>Participants who received the Restoration Modular Hip System.</population>
        <group_list>
          <group group_id="O1">
            <title>Restoration® Modular</title>
            <description>All subjects were enrolled into a single arm and received the Restoration Modular Revision Hip System to replace the femoral portion of a failed previous implant.</description>
          </group>
        </group_list>
        <measure>
          <title>Femoral Stem Fracture</title>
          <population>Participants who received the Restoration Modular Hip System.</population>
          <units>femoral stem fractures</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-surgery Femoral Crack/Fracture and Subsidence Rate</title>
        <time_frame>Post-op to 5 years</time_frame>
        <population>Post-surgery femoral crack/fracture and subsidence rate were assessed by hip.</population>
        <group_list>
          <group group_id="O1">
            <title>Restoration® Modular</title>
            <description>All subjects were enrolled into a single arm and received the Restoration Modular Revision Hip System to replace the femoral portion of a failed previous implant.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-surgery Femoral Crack/Fracture and Subsidence Rate</title>
          <population>Post-surgery femoral crack/fracture and subsidence rate were assessed by hip.</population>
          <units>percentage of hips</units>
          <param>Number</param>
          <units_analyzed>hips</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>hips</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="122"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Post-surgery femoral stem crack/fracture rate %</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Femoral subsidence rate %</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Post-surgery femoral stem crack/fracture rate compared to 21% (pre-specified in protocol based on literature rates) Femoral subsidence rate compared to 18% (pre-specified in protocol based on literature rates)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Exact Binomial</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Enrollment to 5 years post-op. Censored protocol violations not included as at risk participants. Industry standard Adverse Event (AE) terms (e.g. MedDRA) were not used for AE data collection. Specific AE terms were not used for all AEs collected.</time_frame>
      <desc>Serious AEs &amp; AEs related to the implant/procedure collected. Elective procedures not included. i.e. non-study joint replacement/revision, rotator cuff repair, carpal tunnel release, cataract, intra-ocular &amp; bunion procedures, total shoulder repair, laminectomy, microdiscectomy, breast reduction, cervical spine fusion, &amp; mid-foot/flat-foot surgery.</desc>
      <group_list>
        <group group_id="E1">
          <title>Restoration® Modular</title>
          <description>All subjects were enrolled into a single arm and received the Restoration® Modular Revision Hip System to replace the femoral portion of a failed previous implant.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Blood and Lymphatic System Disorders</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Cardiac Disorders</sub_title>
                <counts group_id="E1" events="16" subjects_affected="9" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Gastrointestinal Disorders</sub_title>
                <counts group_id="E1" events="11" subjects_affected="8" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site General Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Hepatobiliary Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Infections and Infestations</sub_title>
                <counts group_id="E1" events="11" subjects_affected="8" subjects_at_risk="120"/>
              </event>
              <event>
                <sub_title>Operative Site Infections or Infestations</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Injury, Poisoning and Procedural Complications</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="120"/>
              </event>
              <event>
                <sub_title>Operative Site Injury, Poisoning and Procedural Complications</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Musculoskeletal and Connective Tissue Disorders</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="120"/>
              </event>
              <event>
                <sub_title>Operative Site Musculoskeletal and Connective Tissue Disorders</sub_title>
                <counts group_id="E1" events="22" subjects_affected="17" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Non-Operative Site Neoplasms Benigh, Malignant, and Unspecified</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Nervous System Disorders</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Renal and Urinary Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Respiratory, Thoracic and Mediastinal Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Skin and Subcutaneous Tissue Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Vascular Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Operative Site Injury,Poisoning and Procedural Complication</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Musculoskeletal and Connective Tissue Disorders</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="120"/>
              </event>
              <event>
                <sub_title>Operative Site Musculoskeleatal and Connective Tissue Disorders</sub_title>
                <counts group_id="E1" events="55" subjects_affected="35" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Each investigator shall have privileges for their own center’s results at the completion of the study.These manuscripts and abstracts will be delayed until after the multi-center publication is submitted.All publications shall be submitted to the Sponsor for review at least 60 days prior to submission of publication.The Sponsor shall not edit or otherwise influence the publications other than to ensure that confidential information is not disclosed and that the data is accurately represented.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Clinical Research</name_or_title>
      <organization>Stryker Orthopaedics</organization>
      <phone>201-831-5401</phone>
      <email>Ellen.Axelson@stryker.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

